A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

NCT00224120 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

462

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Silodosin
OTHER: Placebo

Sponsor

Watson Pharmaceuticals